Not cancer · Austria
Fatty liver disease (MASLD/MASH)
How is it diagnosed today? It is usually found after blood tests or scans done for another reason show signs of problems with your liver. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.6 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Weight loss, healthy diet and exercise. NHS
2 medicines are approved for this disease in Austria:
- Resmetirom (Rezdiffra) – approved in 2025
- Semaglutide (Kayshild, Wegovy Multi FixDose) – approved in 2026
An EU approval is valid in Austria. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Being tested in people
6 open trials in Austria, 271 worldwide. See the trials
- ALN-CIDEB (Phase 3)
- DR10624 Injection (Phase 3)
- Efimosfermin alfa (Phase 3)
- Efruxifermin (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 2 were in animals and 0 in the lab. See them
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Cannabis and cannabinoids (CBD, THC) (only single reports in people)
- Amygdalin (laetrile, "vitamin B17") (animal studies only)
- Mistletoe extract (animal studies only)
- Ivermectin (lab studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
0 open trials in Austria with these filters
We found no open trial in Austria with these filters.
Available abroad (82 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Blood tests and phone programs for heart, kidney and diabetes risk
NCT07820800 · ClinicalTrials.gov
Countries: Finland
- Savonlinna, Finland – Wellbeing Services County of South Savo (Eloisa) (provide social and healthcare services and emergency services in the Enonkoski, Hirvensalmi, Juva, Kangasniemi, Mikkeli, Mäntyharju, Pieksämäki, Puumala, Rantasalmi, Savonlinna ja Sulkava)
Ages 45 to 55
Contact the trial teamScreening tool for fatty liver disease using body impedance measurement
NCT04873258 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge
Ages 18 to 80
Contact the trial teamCompares Weight-Loss Surgery and Medicines for Fatty Liver Scarring
NCT06374875 · ClinicalTrials.gov
Countries: Switzerland, Spain, Finland and 10 more
- Basel, Switzerland – Clarunis Universitäres
- Geneva, Switzerland – Hôpitaux universitaires de Genève
- Barcelona, Spain – Hospital Clinic Barcelona
Ages 18 to 75
Contact the trial teamTesting how fructose sugar affects liver inflammation in people with fatty liver disease
NCT07013916 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Royal London Hospital
- London, United Kingdom – Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London
Ages 45 to 65
Contact the trial teamPectin Supplement Tested for Inflammation and Gut Bacteria in Fatty Liver Disease
NCT07093346 · ClinicalTrials.gov
Countries: United Kingdom
- Nottingham, United Kingdom – Nottingham Clinical Research Facility at Nottingham University Hospitals NHS Trust
- Nottingham, United Kingdom – Sir Peter Mansfield Imaging Centre, University of Nottingham
- Nottingham, United Kingdom – University of Nottingham
Age 18 and over
Contact the trial teamExercise at different intensities for metabolic dysfunction-associated steatotic liver disease
NCT06506513 · ClinicalTrials.gov
Countries: Belgium
- Brussels, Belgium – Cliniques universitaires Saint-Luc
- Louvain-la-Neuve, Belgium – Centre d'investigation clinique en nutrition
Ages 18 to 70
Contact the trial teamTests BI 3804379 Doses in Healthy People and Liver Fibrosis Patients
NCT06575400 · ClinicalTrials.gov
Countries: Belgium
- Edegem, Belgium – SGS Life Science Services - Clinical Research
Ages 18 to 65
Contact the trial teamStudies how gut bacteria produce certain metabolites in people with fatty liver disease
NCT07313007 · ClinicalTrials.gov
Countries: France
- Pierre-Bénite, France – Centre Hospitalier Lyon Sud Service Endocrinologie, Diabète et nutrition
Ages 18 to 80
Contact the trial teamMeal Timing in People With Fatty Liver Disease and in New Mothers
NCT07630636 · ClinicalTrials.gov
Countries: United Kingdom
- Cambridge, United Kingdom – Cambridge Clinical Research Centre
Ages 18 to 80
Contact the trial teamTests TGM-312-SC01 safety in healthy adults and adults with MASH liver disease
NCT07427680 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Richmond Pharmacology
Ages 18 to 70
Contact the trial teamOlive oil intake and liver fat in adults with fatty liver disease
NCT07412444 · ClinicalTrials.gov
Countries: Italy
- Castellana Grotte, Italy – UOS Data Science
Ages 18 to 65
Contact the trial teamExercise and Mediterranean Diet for Obesity and Fatty Liver Disease
NCT06186869 · ClinicalTrials.gov
Countries: Italy
- Castellana Grotte, Italy – IRCCS De Bellis
Ages 18 to 65
Contact the trial teamBuilding virtual models to understand fatty liver disease and predict heart problems
NCT07430501 · ClinicalTrials.gov
Countries: Spain
- Barcelona, Spain – Vall d´Hebron Institute de Recerca (VHIR)
Age 18 and over
Contact the trial teamGenetic Study of Fatty Liver and Blood Clotting Risk in Lombardy
NCT06566105 · ClinicalTrials.gov
Countries: Italy
- Milan, Italy – Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica
Ages 40 to 60
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamUltrasound Image Processing Algorithm for Detecting Fatty Liver Disease
NCT06975579 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – The Royal Marsden Hospital
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamChecking Liver Fat and Eating Habits in Children With Down Syndrome
NCT06888570 · ClinicalTrials.gov
Countries: Spain
- Madrid, Spain – Fundación Jerome Lejeune
Ages 5 to 22
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudies how the liver processes fat and sugar in fatty liver disease
NCT06942312 · ClinicalTrials.gov
Countries: Finland
- Helsinki, Finland – Helsinki Central University Hospital
Ages 18 to 75
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamNon-invasive MRI Test for Scarring in the Liver
NCT05385237 · ClinicalTrials.gov
Countries: Switzerland
- Basel, Switzerland – University Hospital Basel
- Liestal, Switzerland – Kantonsspital Baselland (KSL)
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTesting How Sugars Affect Fat Buildup in the Liver
NCT06751862 · ClinicalTrials.gov
Countries: Czechia
- Prague, Czechia – Institute for Clinical and Experimental Medicine
Ages 18 to 70
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamHow alcohol and fats affect liver cell energy in healthy volunteers
NCT06559878 · ClinicalTrials.gov
Countries: Finland
- Helsinki, Finland – Helsinki Central University Hospital
Ages 18 to 75
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamChecks how common liver scarring is in people living with HIV
NCT04066608 · ClinicalTrials.gov
Countries: Germany
- Mainz, Germany – University Medical Center of the Johannes Gutenberg University
- Mainz, Germany – University Medical Center of the Johannes Gutenber Univeristy
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests timed eating windows for obesity and liver fat in adults
NCT06061042 · ClinicalTrials.gov
Countries: Netherlands
- Amsterdam, Netherlands – Amsterdam UMC, location AMC
Ages 50 to 75
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamFollowing heart attack patients with and without diabetes over time
NCT05046483 · ClinicalTrials.gov
Countries: Germany
- Düsseldorf, Germany – German Diabetes Center
Ages 18 to 80
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudies people with fatty liver disease and related chronic liver conditions
NCT05335603 · ClinicalTrials.gov
Countries: Denmark
- Hvidovre, Denmark – Hvidovre University Hospital
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTesting a care pathway for fatty liver disease in VA primary care
NCT06671886 · ClinicalTrials.gov
Countries: United States
- Houston, United States – Michael E. DeBakey VA Medical Center, Houston, TX
Ages 18 to 80
Contact the trial teamTests INI-822 safety in healthy people and people with MASH liver disease
NCT05945537 · ClinicalTrials.gov
Countries: Australia
- Bedford Park, Australia – Flinders Medical Centre, Flinders Medical Centre, Flinders
- Birtinya, Australia – University of the Sunshine Coast Clinical Trials (Birtinya), UniSC Clinical Trials Vitality Village, Level 4, Tenancy 410, 5 Discovery Court
- Box Hill, Australia – Box Hill Hospital, Level 1, 5 Arnold street
Ages 18 to 70
Contact the trial teamGum health and blood markers in people with fatty liver disease
NCT07923409 · ClinicalTrials.gov
Ages 18 to 65
Contact the trial teamTests semaglutide in adults with fatty liver disease and healthy volunteers
NCT03884075 · ClinicalTrials.gov
Countries: United States
- Bethesda, United States – National Institutes of Health Clinical Center
Ages 18 to 100
Contact the trial teamGlycine supplement for people with fatty liver disease linked to metabolic problems
NCT07285135 · ClinicalTrials.gov
Countries: Singapore
- Singapore, Singapore – Singapore General Hospital
Ages 21 to 70
Contact the trial teamTesting Different Bypass Lengths for Weight Loss Surgery in Adults With Obesity
NCT04841057 · ClinicalTrials.gov
Countries: United States
- Columbia, United States – University of Missouri - Columbia
Ages 18 to 80
Contact the trial teamBlood Abnormalities in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT07872059 · ClinicalTrials.gov
Ages 18 to 80
Contact the trial teamCollects blood and liver samples to study liver diseases
NCT03025074 · ClinicalTrials.gov
Countries: United States
- Buffalo, United States – University at Buffalo, Buffalo General Medical Center
Age 7 and over
Contact the trial teamHeart Risk and Coronary Calcium Scores in Thai Adults With Fatty Liver Disease
NCT07865936 · ClinicalTrials.gov
Countries: Thailand
- Bangkok, Thailand – Faculty of Medicine Siriraj Hospital, Mahidol University
Ages 35 to 75
Contact the trial teamUsing Glucose Sensors to Study Insulin Sensitivity in Diabetes and Fatty Liver Disease
NCT07861191 · ClinicalTrials.gov
Countries: Singapore
- Singapore, Singapore – MD6, Centre for Translational Medicine, 14 Medical Drive, Singapore 117599
Ages 21 to 70
Contact the trial teamHow the body handles one dose of HRS-4729 in people with kidney problems
NCT07807059 · ClinicalTrials.gov
Countries: China
- Chengdu, China – Sichuan Provincial People's Hospital
Ages 18 to 65
Contact the trial teamUltrasound Methods to Diagnose Advanced Fatty Liver Disease Without Biopsy
NCT03572465 · ClinicalTrials.gov
Countries: Canada
- Montreal, Canada – Centre Hospitalier de l'Université de Montréal
Age 18 and over
Contact the trial teamSafety study of OPK-88006 in healthy adults and adults with fatty liver disease
NCT07512427 · ClinicalTrials.gov
Countries: United States
- Miami, United States – hospital not given
Ages 18 to 75
Contact the trial teamTests alpelisib's effect on insulin and liver sugar and fat
NCT06354088 · ClinicalTrials.gov
Countries: United States
- New York, United States – Columbia University Irving Medical Center
Ages 18 to 70
Contact the trial teamStudying people at higher risk of cancer to find early warning signs
NCT05463796 · ClinicalTrials.gov
Countries: United States
- Boston, United States – Dana-Farber Cancer Institute
No age limit given in the registry
Contact the trial teamStudying Fat-Tissue Immune Cells in Obesity and Lean Adults
NCT06335771 · ClinicalTrials.gov
Countries: United States
- Columbia, United States – University of Missouri School of Medicine
Ages 18 to 70
Contact the trial team
Showing 40 of 82. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- ReviewStage-Dependent Roles of PANoptosis in MASLD: From Isolated Steatosis to Hepatocellular Carcinoma.Cell Biochem Funct · 2026-11-01
- In peopleBioinformatics and Machine Learning Identify Key Genes in Mitochondrial Homeostasis and Immune Infiltration in Metabolic Dysfunction-Associated Steatotic Liver Disease Progression.Biomed Res Int · 2026-01-01
- KASL Consensus Statement for Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatohepatitis: Focus on Semaglutide.Clin Mol Hepatol · 2026-11-17
- Cardiometabolic index fails to discriminate the histological status of metabolic dysfunction-associated steatotic liver disease patients: A report from biopsy-proven Turkish metabolic dysfunction-associated steatotic liver disease cohort.Hepatol Forum · 2026-10-30
- In peopleClinical Impact of the AISF STEPS-MASH Algorithm: Real-World Application in Tertiary Hepatology Practice.Liver Int · 2026-12-01
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Hepatitis Hilfe Österreich – Plattform Gesunde Leber
Nationwide non-profit patient organisation for all liver diseases, founded in 1999 by patients: counselling, information leaflets and support for patients and relatives.
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (4)
- European Liver Patients' Association (ELPA)
European umbrella of national liver patient groups: liver disease information, HCC patient guide (with ESMO), clinical trial finder and liver cancer advocacy; points patients to member groups.
- Global Liver Institute (GLI)
Global liver health advocacy body with a Liver Cancers Council, patient/caregiver education events and advocate training; not a direct support service.
Phone: +1 800 845 5910
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.